Sign up to save your podcasts
Or
Share MENA emerging as trial destination says ClinTec CEO
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
MENA emerging as trial destination says ClinTec CEO
Improving healthcare infrastructure across the region and a large treatment-naïve patient population makes the Middle East and North Africa (MENA) an increasingly attractive destination for drug trials says ClinTec CEO Rabinder Buttar.
View all episodes
By William Reed LtdImproving healthcare infrastructure across the region and a large treatment-naïve patient population makes the Middle East and North Africa (MENA) an increasingly attractive destination for drug trials says ClinTec CEO Rabinder Buttar.